US2019350936A1PendingUtilityA1
Method for promoting wound healing by administering a compound which binds ldl-receptor-related protein (lrp) ligand binding domain
Est. expirySep 22, 2023(expired)· nominal 20-yr term from priority
Inventors:Elazar RabbaniXiaofeng LiDakai LiuYazhou ZhangRichard JinRiddhi BhattacharyyaWei ChengJames J. Donegan
G01N 33/5041A61K 31/185A61K 31/538A61P 3/10A61K 31/015G01N 33/5011A61K 31/235A61K 38/00G01N 2800/24G01N 33/92G01N 2333/705A61K 31/535G01N 33/564A61K 31/192A61K 31/395
72
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to the field of therapeutic methods, compositions and uses thereof, that affect, directly or indirectly, the behavior of LRP receptors. These compositions and methods result in the treatment of inflammatory, immunological and metabolic conditions. More particularly, the methods and compositions of the invention are directed to the identification of small molecules, drugs and/or pharmacological agents that affect the Wnt pathway by affecting normal complex formation among various signaling receptors, the LRP5 and LRP6 receptor, and related ligands.
Claims
exact text as granted — not AI-modified1 . A method for treating Diabetes mellitus in a human patient, comprising: administering to a human patient in need of treatment for Diabetes mellitus an effective amount of digallic acid.
Join the waitlist — get patent alerts
Track US2019350936A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.